Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Dissociation Market

Cell Dissociation Market Size

  • Report ID: GMI6854
  • Published Date: Oct 2023
  • Report Format: PDF

Cell Dissociation Market Size

Cell Dissociation Market size was valued to be USD 378.3 million in 2022 and is expected to reach USD 1.6 billion in 2032, growing at a CAGR of 15.3% by 2032 driven by the rising focus on the development of cell-based therapeutics that has led to the development of patient-specific cell therapies.

 

Cell dissociation is essential for isolating and culturing cells. Also, there is a notable increase in interest and investment in cell-based research. Government, private firms, and biotechnology companies are dedicating substantial resources to support cell therapy technologies in areas such as stem cell biology, regenerative medicine, and immunotherapy. For instance, the U.S. National Institutes of Health (NIH) allocate significant funds around a billion dollars per year to support stem cell research. Additionally, collaborations and partnerships between academia and industry are common, facilitating research translation.

 

Cell dissociation refers to the process of separating and isolating individual cells or cell clusters from a tissue, organ, or cell culture. This process typically involves breaking down cell-to-cell and cell-to-substrate adhesions to release the constituent cells, allowing them to be suspended as individual entities in a solution.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size for cell dissociation reached USD 378.3 million in 2022 and is expected to grow at 15.3% CAGR from 2023 to 2032 attributed to the rising focus on the development of cell-based therapeutics and the higher development of patient-specific cell therapies.

The tissue dissociation application segment is expected to reach USD 842.5 million by 2032 attributed to applicability in wide range of research areas.

North America held 37.2% of the market in 2022 and will exhibit considerable growth 2023-2032 driven by the favorable government initiatives coupled with the presence of numerous pharmaceutical and biotechnology companies.

Merck KGaA, Thermo Fisher Scientific, Danaher Corp, STEMCELL Technologies, Sartorius AG, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd, S2 Genomics, Inc., and Nuromics are among the top companies engaged in the cell dissociation industry.

Cell Dissociation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 263
  • Countries covered: 21
  • Pages: 150
 Download Free Sample